Tumor uptake of this 18F-labeled HER2 aptamer in BT474 xenograft models was rather low at 0.62 ± 0.04% ID/g at 1 h p. i., but was higher than that in the HER2-negative MDA-MB-231 xenograft models. Here, ERBB2 is linked to neoplasm.